With regard to pro-inflammatory biomarkers, higher baseline interleukin-6 (IL-6) levels have been reported to be associated with increased fasting insulin, insulin resistance, and β-cell function in the nondiabetic Whitehall II study cohort, while higher baseline adiponectin levels were associated with decrements in fasting glucose and insulin [71]. This evidence concerns the gene INS and Insulin resistance.